FOXO3 and neoplasm: FOXA1 is a central regulator of gene expression programs in ER+ breast cancer (30), FOXC1 is associated with EMT and poor prognosis in basal-like breast cancer (31), and FOXO3 is often dysregulated and plays both tumor-suppressive and oncogenic roles (32, 33).